Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Krystal Biotech (KRYS) Long-Term Investments (2021 - 2026)

Krystal Biotech's Long-Term Investments history spans 6 years, with the latest figure at $193.5 million for Q1 2026.

  • On a quarterly basis, Long-Term Investments rose 30.32% to $193.5 million in Q1 2026 year-over-year; TTM through Mar 2026 was $193.5 million, a 30.32% increase, with the full-year FY2025 number at $128.1 million, down 15.81% from a year prior.
  • Long-Term Investments hit $193.5 million in Q1 2026 for Krystal Biotech, up from $128.1 million in the prior quarter.
  • Over the last five years, Long-Term Investments for KRYS hit a ceiling of $193.5 million in Q1 2026 and a floor of $4.6 million in Q4 2022.
  • Historically, Long-Term Investments has averaged $79.3 million across 5 years, with a median of $69.3 million in 2024.
  • Biggest five-year swings in Long-Term Investments: tumbled 92.82% in 2022 and later surged 1537.67% in 2024.
  • Tracing KRYS's Long-Term Investments over 5 years: stood at $4.6 million in 2022, then skyrocketed by 1240.71% to $62.0 million in 2023, then surged by 145.53% to $152.1 million in 2024, then fell by 15.81% to $128.1 million in 2025, then skyrocketed by 51.08% to $193.5 million in 2026.
  • Business Quant data shows Long-Term Investments for KRYS at $193.5 million in Q1 2026, $128.1 million in Q4 2025, and $133.1 million in Q3 2025.